
Journal of Medicinal Chemistry p. 709 - 714 (1982)
Update date:2022-08-05
Topics:
Leclerc, Gerard
Decker, Nicole
Schwartz, Jean
A series of 24 cyclohexylaralkylamine derivatives related to perhexilene has been synthesized and screened for cardiovascular activity.All the compounds contained an exocyclic amine which was substituted either by an alkyl, cycloalkyl, or aralkyl group.In the hope of further reducing toxicity, the synthesis of p-tolyl- and p-hydroxyphenyl derivatives 23 and 24 was undertaken.The effect of separating the cyclohexylamine moiety with respect to the aromatic nucleus has been systematically examined.The pharmacological investigations were directed to a search for compounds having an activity better than perhexiline according to the following order of criteria: (1) α-adrenolytic activity; (2) increase of coronary blood flow; (3) calcium antagonism.Several compounds were more potent and exhibited lower toxicity than perhexiline.Further detailed pharmacological investigations (tension time index and decreased cardiac work) have led to the selection of N,2-dicyclohexyl-2-phenethylamine (3) for clinical trials, which are now under way.
View Morewebsite:http://www.antaibio.com
Contact:0086-21-65663057
Address:Room 2108, Building 2,No. 489 Zhengli Road,200433
Reliable Pharma Technology (Shanghai) Co., Ltd.
Contact:0086-21-67676847-8008
Address:Lane 1500, No.68, Xinfei Road, Songjiang District, Shanghai, 201611, P.R.China.
Contact:+86-0592 5353131
Address:No.56 Guani Road Software Park 2,Siming District
Huzhou City Linghu Xinwang Chemical Co.,Ltd.
Contact:86-572-3948695/3945236
Address:huzhou
Dayang Chem (Hangzhou) Co.,Ltd.
website:http://www.dycnchem.com
Contact:+86-571-88938639
Address:9/F, Unit 2 Changdi Torch Building, 259# WenSan Road, Xihu District, Hangzhou City 310012, P.R.China
Doi:10.1007/BF00799022
(1982)Doi:10.1021/ja00376a017
(1982)Doi:10.1055/s-2006-948182
(2006)Doi:10.1016/j.tetasy.2004.08.037
(2004)Doi:10.1021/ja0484597
(2004)Doi:10.1039/P29880001045
(1988)